• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    'Graft-on-a-Chip' Built to Improve Vascular Graft Success

    Abbott Invests €440 in New Irish Facility

    FDA Approves Guardant Health's NGS-Based Companion Diagnostic

    Reflow Medical Completes DEEPER LIMUS Clinical Trial Enrollment

    NanoVibronix Strengthening its Supply Chain to Address Potential Delays
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Cooling and Melting the Pain Away

    What Are the Fundamentals of Go-To-Market Strategy in Medical Devices?

    Minding the Gap: How Harmonizing Quality Systems Pays Off

    Building Strong Partnerships Between Medtech and Surgeon-Learning Platforms

    Four Key Considerations for OEMs Transferring a Product Program
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Xact Wire EDM Corp.

    Concise Engineering

    JBC Technologies

    Arthur G. Russell Co. Inc., The

    Cirtec Medical
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Medical Computing: COM Express Processes Real-Time Data at the Edge

    The Importance of Building Successful Supplier Relationships

    The Benefits of Outsourcing Innovation in Medtech Manufacturing

    Patching Healthcare Cybersecurity Risks in the Internet of Medical Things

    Leveraging Open Healthcare Data Standards to Improve Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Xact Wire EDM Corp.

    Concise Engineering

    JBC Technologies

    Arthur G. Russell Co. Inc., The

    Cirtec Medical
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    Medtech Funding: Emerging from the Valley of Death?

    ...

    Medtech Funding: Emerging from the Valley of Death?
    Related CONTENT
    • Former Medtronic, St. Jude Executive Assumes CCO Role at JenaValve
    • FDA Approves Boston Scientific's Eluvia Drug-Eluting Stent
    • Boston Scientific to Acquire Augmenix for Up to $600 Million
    • Premium Medtech Price Strategies for the Robotics Segment
    • Boston Scientific to Acquire VENITI for $108M
    Maria Shepherd, President and Founder, Medi-Vantage10.16.18
    The number of conferences focused on finding funding in the life sciences and medtech space continues to increase. Two of them—the RESI meeting (Redefining Early Stage Investments, held in Boston, Mass., on Sept. 6) and the McDermott Life Sciences Dealmaking Symposium (to be held Oct. 10, 2018 in Cambridge, Mass.)—feature early-stage investors, fundraising CEOs, entrepreneurs, strategic partners, and service providers who attend these meetings to learn about each other and discover best practices for strategy and transactions.

    Why This Is Important
    One big takeaway from the RESI meeting was the sheer number of incubators and accelerators focused on life sciences that have emerged over the past five years. These programs are technology engines increasing the success rates of startups. According to one website,1 there are 227 accelerators in the United States and 243 entrepreneurship programs at universities across America that self-identify as startup accelerators with dedicated centers for entrepreneurship (Chart 1).


    Chart 1: Number of Accelerators and University Programs in the U.S.1

    The help provided by these programs is desperately needed. While startups in healthcare are among those with the lowest failure rates compared to other industry sectors, the harsh reality is that only an estimated 56 percent are still operating after four years.2 Incubators, accelerators, and strong academic institutions have service providers able to assist in the design, development, and clinical testing of a device, as well as market assessment and analysis. Further, they can connect startups to groups of experienced entrepreneurs willing to take new technologies to and beyond the point of commercialization.

    Who Are the Investors?
    Ambitious entrepreneurs who wish to make their startups successful need to understand who the partners and investors are, and what they want. Strategic partners at the RESI meeting stated that there are two types of startup companies—those that have a perfect strategic fit with their divisions (the smaller group), and those who are forging ahead with new devices that may have high value, but a poor strategic fit (the larger group). At the end of the day, a strategic partner has to be able to sell the device through its business units, so strategic fit is important to success. In Chart 2, investor types that routinely (or not so routinely) invest in startups are presented. In the same article,3 Life Sciences Nation founder and CEO Dennis Ford presents several key criteria that investors use to evaluate early-stage opportunities. The message? Tailor the presentation you make to investors by type to specifically address their investment goals.


    Chart 2: Percentages of Investor Types Seeking Global Opportunities3
    Original source: LSN Investor Platform, as of October 1, 2015

    Our Medtech Ecosystem Is Changing
    The RESI event was truly a global meeting. Most impressive was the number of Asian investors in attendance who were seeking opportunities (Chart 3). Asian medtech/life sciences investors are back in the game and attended the RESI meeting to assess investments or technology licensing outside of Asia. Asian investors know that markets for life science companies have high potential for a profitable exit. U.S. companies are especially attractive because of the strong ecosystem for innovation support, as illustrated in Chart 1.


    Chart 3. Number of Asian Investors Reviewing Western Healthcare Opportunities3
    Original source: LSN Investor Platform, as of October 1, 2015

    In addition, there are a large number of interested and well-funded investors in Asia and a relatively low number of life science companies located there, increasing the demand for overseas assets. According to the article,3 some Asian investors may solely be motivated to invest to obtain the right to distribute in their local geographies, instead of acquiring sole global ownership of the asset.

    The Medi-Vantage Perspective
    As evidenced by attendance at the RESI meeting, the number of Asian investors has grown as compared to those presented in the referenced article, written in 2015.3 Accepting investment in return for local geographic distribution rights is attractive to cash-starved startups, since Asian investors often have robust relationships with manufacturers and distribution channels in their local geography and can become a resource for taking market share in Asia for your medtech product. The conundrum is that strategic partners like Medtronic or Boston Scientific want worldwide rights to a product they acquire. Be sure your contracts for local geographic distribution rights contain an escape clause that supports your global strategy. 

    References
    1. http://bit.ly/mpo181001
    2. http://bit.ly/mpo181002
    3. http://bit.ly/mpo181003

    Maria Shepherd has more than 20 years of leadership experience in medical device/life science marketing in small startups and top-tier companies. After her industry career, including her role as vice president of marketing for Oridion Medical, where she boosted the company valuation prior to its acquisition by Covidien/Medtronic, director of marketing for Philips Medical, and senior management roles at Boston Scientific Inc., she founded Medi-Vantage. Medi-Vantage provides marketing, business strategy, and innovation research for the medical device, diagnostic, and digital health industries. The firm quantitatively and qualitatively sizes and segments opportunities, evaluates new technologies, provides marketing services, and assesses prospective acquisitions. Shepherd has taught marketing and product development courses and is a member of the Aligo Medtech Investment Committee (www.aligo.com). She can be reached at 855-343-3100. Visit her website at www.medi-vantage.com.
    Related Searches
    • ceo
    • vice president
    • president
    • commercialization
    Suggested For You
    Former Medtronic, St. Jude Executive Assumes CCO Role at JenaValve Former Medtronic, St. Jude Executive Assumes CCO Role at JenaValve
    FDA Approves Boston Scientific FDA Approves Boston Scientific's Eluvia Drug-Eluting Stent
    Boston Scientific to Acquire Augmenix for Up to $600 Million Boston Scientific to Acquire Augmenix for Up to $600 Million
    Premium Medtech Price Strategies for the Robotics Segment Premium Medtech Price Strategies for the Robotics Segment
    Boston Scientific to Acquire VENITI for $108M Boston Scientific to Acquire VENITI for $108M
    AI and Healthcare’s Promising Future AI and Healthcare’s Promising Future
    Addressing Peak Issues in Medtech Addressing Peak Issues in Medtech
    Boston Scientific Recommends Stockholders Reject Boston Scientific Recommends Stockholders Reject 'Mini-Tender' Offer by TRC Capital
    What a Long, Strange Trip It’s Been… What a Long, Strange Trip It’s Been…
    Boston Scientific Launches HeartLogic Heart Failure Diagnostic in Europe Boston Scientific Launches HeartLogic Heart Failure Diagnostic in Europe
    Boston Scientific Responds to Boston Scientific Responds to '60 Minutes' Transvaginal Mesh Report
    Pharma Industry’s Growth—What Can Medtech Learn from It? Pharma Industry’s Growth—What Can Medtech Learn from It?

    Related Breaking News

    • Former Medtronic, St. Jude Executive Assumes CCO Role at JenaValve

      Former Medtronic, St. Jude Executive Assumes CCO Role at JenaValve

      Company is pursuing FDA pre-market approval for its Pericardial TAVR System.
      Business Wire 11.04.20

    • Cardiovascular | Surgical
      FDA Approves Boston Scientific

      FDA Approves Boston Scientific's Eluvia Drug-Eluting Stent

      First tech in U.S. to offer sustained release of antiproliferative drug to treat patients with peripheral artery disease.
      Boston Scientific 09.24.18

    • Surgical
      Boston Scientific to Acquire Augmenix for Up to $600 Million

      Boston Scientific to Acquire Augmenix for Up to $600 Million

      Acquisition expands portfolio of men's health in-office procedures with adjunctive therapy for prostate cancer patients.
      Boston Scientific 09.07.18


    • Surgical
      Premium Medtech Price Strategies for the Robotics Segment

      Premium Medtech Price Strategies for the Robotics Segment

      ...
      Maria Shepherd, President and Founder, Medi-Vantage 09.07.18

    • Cardiovascular | Surgical
      Boston Scientific to Acquire VENITI for $108M

      Boston Scientific to Acquire VENITI for $108M

      Acquisition to bolster company's Venous Therapies portfolio within Peripheral Interventions Division.
      PR Newswire 08.08.18

    Loading, Please Wait..

    Trending
    • Cardinal Health CEO Mike Kaufmann Steps Down
    • BD Recalls Intraosseous Products Over Multiple Issues
    • Medidata Unveils New Tech To Improve Clinical Trial Oversight
    • How To Overcome The Top 6 Medical Device Manufacturing Challenges
    • Chronic, Infectious Disease Prevalence To Benefit Vital Signs Monitoring Market
    Breaking News
    • 'Graft-on-a-Chip' Built to Improve Vascular Graft Success
    • Abbott Invests €440 in New Irish Facility
    • FDA Approves Guardant Health's NGS-Based Companion Diagnostic
    • Reflow Medical Completes DEEPER LIMUS Clinical Trial Enrollment
    • NanoVibronix Strengthening its Supply Chain to Address Potential Delays
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Parylene Coatings for Medical Device Technologies
    • Nearshoring Trends in Medtech Manufacturing
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Charlotte’s Web Sports Product Line to Undergo NSF Certification Process
    ADM and Benson Hill Partner to Scale High Protein Soy for U.S. Market
    Tazo Transitions to Regenerative Organic Agriculture
    Coatings World

    Latest Breaking News From Coatings World

    SONGWON Industrial Group Reports Strong Q2 Financial Results
    PPG Completes COLORFUL COMMUNITIES Project for Boys & Girls Clubs of Greater Houston
    Paul N. Gardner Now Offers Bacharach Sling Psychrometer
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    'Graft-on-a-Chip' Built to Improve Vascular Graft Success
    Abbott Invests €440 in New Irish Facility
    FDA Approves Guardant Health's NGS-Based Companion Diagnostic
    Contract Pharma

    Latest Breaking News From Contract Pharma

    AskBio Appoints Clinical Ops Executives
    SpectrumX Partners With UK Contract Manufacturer
    GL Chemtec Partners with Edgewater Capital to Accelerate Growth
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Arkay Chairman Emeritus Howard Kaneff Has Died
    Nutricosmetics Market to Hit $13.7 Billion by 2030
    Estée Lauder Pledges 100% Electric Fleet of Vehicles by 2030
    Happi

    Latest Breaking News From Happi

    J&J To Stop Global Sales of Talc-Based Products by 2023
    Net Sales Increase 2% for Naples Soap Company in Second Quarter
    Net Revenue Down 12% for Grove Collaborative in Second Quarter
    Ink World

    Latest Breaking News From Ink World

    Heidelberg Enjoys Successful Start to 2022-23 Fiscal Year
    Mimaki Announces New LATAM Website
    Paul N. Gardner Offers Bacharach Sling Psychrometer
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Esko, Constantia Flexibles announce acquisitions and more
    Hybrid Software joins The Flexo Xperience Center
    Flexo Wash LLC and Mike Potter celebrate 20 years
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Focke & Co. to Host Destination: Your Hygiene Hub on August 31
    Exports Dominate Chinese Trade of Tissues, Hygiene Products and Wipes
    Freudenberg to Present Friction Inserts for Wind Energy
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Dental 3D Printing Market is Expanding 20% Annually
    Study Results Released for Abbott's Concussion Blood Test
    Bone Growth Stimulators Market to Top $3B by 2030
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    eMagin Corporation Announces 2Q 2022 Results
    Zebra Technologies’ Emission Reduction Targets Validated by SBTi
    Identiv Delivers Impressive 41% Year-over-Year Growth in RFID Business

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login